Study of Pralatrexate vs. Erlotinib for Non-Small Cell Lung Cancer After at Least 1 Prior Platinum-based Treatment
Clinical trial NCT00606502 · COMPLETED
Trial details
- NCT number
- NCT00606502
- Sponsor
- Spectrum Pharmaceuticals, Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-01
- Primary completion
- 2010-06-24
- Enrollment
- 201
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.